Howell SB - Search Results

1

Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-catenin.

Shang X, Lin X, Howell SB. Shang X, et al. Among authors: howell sb. Cell Commun Signal. 2014 Oct 25;12:59. doi: 10.1186/s12964-014-0059-5. Cell Commun Signal. 2014. PMID: 25344320 Free PMC article.

2

Effect of loss of DNA mismatch repair on development of topotecan-, gemcitabine-, and paclitaxel-resistant variants after exposure to cisplatin.

Lin X, Howell SB. Lin X, et al. Among authors: howell sb. Mol Pharmacol. 1999 Aug;56(2):390-5. doi: 10.1124/mol.56.2.390. Mol Pharmacol. 1999. PMID: 10419559

3

The role of DNA mismatch repair in cisplatin mutagenicity.

Lin X, Kim HK, Howell SB. Lin X, et al. Among authors: howell sb. J Inorg Biochem. 1999 Oct;77(1-2):89-93. doi: 10.1016/s0162-0134(99)00134-8. J Inorg Biochem. 1999. PMID: 10626359 Review.

4

p53 interacts with the DNA mismatch repair system to modulate the cytotoxicity and mutagenicity of hydrogen peroxide.

Lin X, Ramamurthi K, Mishima M, Kondo A, Howell SB. Lin X, et al. Among authors: howell sb. Mol Pharmacol. 2000 Dec;58(6):1222-9. doi: 10.1124/mol.58.6.1222. Mol Pharmacol. 2000. PMID: 11093757

5

P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.

Lin X, Ramamurthi K, Mishima M, Kondo A, Christen RD, Howell SB. Lin X, et al. Among authors: howell sb. Cancer Res. 2001 Feb 15;61(4):1508-16. Cancer Res. 2001. PMID: 11245458

6

Quantification of tumor cell injury in vitro and in vivo using expression of green fluorescent protein under the control of the GADD153 promoter.

Lin X, Gately DP, Hom D, Mishima M, Los G, Howell SB. Lin X, et al. Among authors: howell sb. Int J Cancer. 2001 Feb 15;91(4):555-62. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1083>3.0.co;2-q. Int J Cancer. 2001. PMID: 11251981

7

Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair.

Kondo A, Safaei R, Mishima M, Niedner H, Lin X, Howell SB. Kondo A, et al. Among authors: howell sb. Cancer Res. 2001 Oct 15;61(20):7603-7. Cancer Res. 2001. PMID: 11606400

8

Identification of genes that mediate sensitivity to cisplatin.

Niedner H, Christen R, Lin X, Kondo A, Howell SB. Niedner H, et al. Among authors: howell sb. Mol Pharmacol. 2001 Dec;60(6):1153-60. Mol Pharmacol. 2001. PMID: 11723219 Review.

9

The cellular pharmacology of oxaliplatin resistance.

Mishima M, Samimi G, Kondo A, Lin X, Howell SB. Mishima M, et al. Among authors: howell sb. Eur J Cancer. 2002 Jul;38(10):1405-12. doi: 10.1016/s0959-8049(02)00096-5. Eur J Cancer. 2002. PMID: 12091073

10

The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.

Lin X, Okuda T, Holzer A, Howell SB. Lin X, et al. Among authors: howell sb. Mol Pharmacol. 2002 Nov;62(5):1154-9. doi: 10.1124/mol.62.5.1154. Mol Pharmacol. 2002. PMID: 12391279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters